$RMBS

Rambus stock price target maintained at $165 by StoneX on product momentum

StoneX maintained a Buy rating and $165 price target on Rambus (NASDAQ:RMBS) after its Q3 2026 results and Q4 guidance beat expectations. The company reported $0.84 EPS and $218.3M revenue, driven by strong product and silicon IP demand. Other analysts raised targets but kept Neutral ratings. Rambus shares are down 50% from their 52-week high, trading at 29x StoneX's earnings estimates.

Original reporting
Published Oct 27, 2026, 2:44 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 27, 2026, 2:49 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$RMBS
Bullish
high confidence
Mentioned
$RMBS · $SNEX
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$RMBSBullishMed
01

Why it matters

The earnings beat and raised guidance reinforce the buy rating, likely supporting a short‑term rally.

02

Market read

Rambus' earnings exceed expectations, prompting analyst optimism and possible price appreciation.

03

What to watch

Potential supply‑chain constraints or competitive pressure from larger memory IP players.

Relevance 7/10Novelty 8/10Timing: post‑earnings today

Background

Rambus (NASDAQ:RMBS) is a semiconductor company focused on memory interface products and silicon IP.

Company-level read

Ticker impact

$RMBSBullishHigh confidence
Context

StoneX reiterated a Buy rating and $165 price target after Rambus reported better‑than‑expected Q3 2026 results and raised Q4 guidance.

Expected impact

potential upward pressure as the market prices in the strong earnings and guidance

Evidence & confidence

Earnings beat and raised guidance are fresh primary information; analysts view the stock as undervalued.

Market effects

Positive earnings may lift other semiconductor memory and IP firms.

U.S. tech sector could see modest gains.

Limited to semiconductor niche, no broad macro effect.

Counterpoint

The stock remains down 50% YTD; valuation may already be stretched despite the beat.

Key entities

  • StoneX

    Research firm that reiterated a Buy rating and $165 price target.

Related articles

$COHRMed

Coherent Soars 6%, Lumentum Up 8% as StoneX Starts Both With Buy, Sees 103% Upside

Coherent (COHR) and Lumentum (LITE) shares rose 6% and 8% respectively after StoneX initiated coverage with Buy ratings and price targets of $425 and $1,200. StoneX cites Coherent's six-inch InP laser production and Lumentum's market position in high-speed InP lasers and cloud transceivers. Coherent's earnings estimates have been rising, with fiscal 2027 EPS expected at $9.39. StoneX's target implies a 45x multiple on fiscal 2027 earnings, above Coherent's five-year average of 24x.

High

Lumentum Stock Jumps 8% on StoneX $1,200 Target

Lumentum's stock rose 8.19% to $818.10 after StoneX initiated coverage with a Buy rating and a $1,200 price target. The company's products are used in AI and data-center infrastructure. Coherent and Applied Optoelectronics also gained. Lumentum's next earnings report is due on 5 November.

$RMBSMedAI 8/10

Rambus Inc (RMBS) (Q3 2026) Earnings Call Highlights: Record Revenue and EPS as DDR5

Rambus Inc (RMBS) reported record revenue and EPS for Q3 2026, driven by DDR5 demand. Q4 guidance shows 34% YoY growth, with RCDs leading. MRDIMM ramp may be slower due to platform adoption and memory despecing. Gross margins were at the lower end of the 60-63% range due to supply chain costs. CEO Luc Seraphin expressed optimism for 2027, despite supply chain challenges and limited visibility into customer inventory.